Skip to main content
editorial
. 2016 Mar 30;7(17):22971–22972. doi: 10.18632/oncotarget.8502

Figure 1.

Figure 1

SIRT2-selective inhibitor TM represses tumor cell growth by promoting the proteolytic degradation of Myc.